PANACEA LIFE SCIENCES HOLDINGS, INC. Quarterly Interest Expense in USD from Q3 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Panacea Life Sciences Holdings, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2016 to Q1 2024.
  • Panacea Life Sciences Holdings, Inc. Interest Expense for the quarter ending March 31, 2024 was $430K, a 13% increase year-over-year.
  • Panacea Life Sciences Holdings, Inc. Interest Expense for the twelve months ending March 31, 2024 was $1.61M, a 16.7% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. annual Interest Expense for 2023 was $1.56M, a 24% decline from 2022.
  • Panacea Life Sciences Holdings, Inc. annual Interest Expense for 2022 was $2.05M, a 85.3% increase from 2021.
  • Panacea Life Sciences Holdings, Inc. annual Interest Expense for 2021 was $1.11M, a 26.9% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.61M $430K +$49.5K +13% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.56M $412K +$33.2K +8.77% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.52M $397K -$201K -33.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.72M $367K -$203K -35.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-15
Q1 2023 $1.93M $380K -$121K -24.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $2.05M $379K +$55.4K +17.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $1.99M $598K +$423K +242% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.57M $570K +$286K +100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 $1.28M $501K +$179K +55.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $1.11M $324K -$72.7K -18.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.18M $175K -$258K -59.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.44M $284K -$110K -27.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $1.55M $323K +$34.1K +11.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $1.51M $396K +$288K +267% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $1.22M $433K +$431K +20466% Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-12-20
Q2 2020 $792K $394K +$392K +18614% Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-12-20
Q1 2020 $401K $288K -$78.4K -21.4% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-27
Q4 2019 $479K $108K +$26.5K +32.5% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-23
Q3 2019 $453K $2.11K -$125K -98.3% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $578K $2.11K -$142K -98.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-18
Q1 2019 $720K $367K +$256K +230% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 $464K $81.5K +$30.3K +59.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-22
Q3 2018 $434K $127K +$110K +632% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $324K $145K +$145K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $180K $111K +$111K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 $68.6K $51.2K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 $17.4K +$17.4K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-20
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q3 2016 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.